Formulation design studies of atenolol tablets.
Moneghini
M
M
Department of Pharmaceutical Sciences, University of Trieste, Italy. moneghin@univ.trieste.it
Carcano
A
A
Perissutti
B
B
Rubessa
F
F
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000737:chemistry; D001262:Atenolol / Q000008:administration & dosage* / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D004339:Drug Compounding; D005079:Excipients; D006244:Hardness; D006863:Hydrogen-Ion Concentration; D011208:Powders; D012995:Solubility; D013607:Tablets
D000319:Adrenergic beta-Antagonists; D005079:Excipients; D011208:Powders; D013607:Tablets; D001262:Atenolol